The effect of BMI on the outcomes of CDK 4/6 inhibitor therapy in HR-positive metastatic breast cancer patients.

Creative Commons License

Çağlayan D., Koçak M. Z., Geredeli Ç., Tatlı A. M., Eryılmaz M. K., Sezgin Göksu S., ...More

2022 ASCO Annual Meeting, Illinois, United States Of America, 2 - 06 June 2022, pp.13010, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • City: Illinois
  • Country: United States Of America
  • Page Numbers: pp.13010
  • Akdeniz University Affiliated: Yes